These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8969311)

  • 1. Is there a need for standardization of methods in economic evaluations of medicine?
    Rittenhouse BE
    Med Care; 1996 Dec; 34(12 Suppl):DS13-22. PubMed ID: 8969311
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardization of the economic evaluation of health technologies. European developments.
    Rovira J
    Med Care; 1996 Dec; 34(12 Suppl):DS182-8. PubMed ID: 8969325
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of Swedish health economics research.
    Drummond M; Botten G; Häkkinen U; Pedersen KM
    Scand J Public Health Suppl; 2006 Dec; 68():5-43. PubMed ID: 17366872
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations].
    Postma MJ; Kwik JJ; Rutten WJ; de Jong-van den Berg LT; Brouwers JR
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1082-7. PubMed ID: 12085558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the quality of Swedish health economics research.
    Drummond MF; Botten G; Häkkinen U; Pedersen KM
    Scand J Public Health; 2006; 34(6):566-7. PubMed ID: 17132588
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating the quality of published pharmacoeconomic evaluations.
    Sanchez LA
    Hosp Pharm; 1995 Feb; 30(2):146-8, 151-2. PubMed ID: 10140528
    [No Abstract]   [Full Text] [Related]  

  • 7. Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal.
    Weisman MH; Gano AD; Gabriel SE; Hochberg MC; Kavanaugh A; Ofman JJ; Prashker M; Suarez-Almazor ME; Yelin E; Nakelsky SD; Croft JD;
    J Rheumatol; 2003 Aug; 30(8):1739-47. PubMed ID: 12913929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesizing evidence from multiple studies. The role of meta-analysis in pharmacoeconomics.
    Lafata JE; Koch GG; Ward RE
    Med Care; 1996 Dec; 34(12 Suppl):DS136-45. PubMed ID: 8969322
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case.
    Maetzel A; Tugwell P; Boers M; Guillemin F; Coyle D; Drummond M; Wong JB; Gabriel SE;
    J Rheumatol; 2003 Apr; 30(4):891-6. PubMed ID: 12672224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can pharmacoeconomic guidelines be implemented successfully in Asia?
    Li SC
    J Med Econ; 2008; 11(2):341-3. PubMed ID: 19450090
    [No Abstract]   [Full Text] [Related]  

  • 11. The Danish approach to standards for economic evaluation methodologies.
    Alban A; Gyldmark M; Pedersen AV; Søgaard J
    Pharmacoeconomics; 1997 Dec; 12(6):627-36. PubMed ID: 10175975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial development of the Australian Guidelines.
    Freund DA
    Med Care; 1996 Dec; 34(12 Suppl):DS211-5. PubMed ID: 8969328
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of pharmacoeconomics analyses to health protection].
    Drozd M
    Wiad Lek; 2002; 55 Suppl 1():76-9. PubMed ID: 15002222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for pharmacoeconomic and outcomes research fellowship training programs: joint guidelines from the american college of clinical pharmacy and the international society of pharmacoeconomics and outcomes research.
    Kane-Gill S; Reddy P; Gupta SR; Bakst AW
    Pharmacotherapy; 2008 Dec; 28(12):1552. PubMed ID: 19025439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economics--what the nephrologist should know.
    Palmer AJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1038-41. PubMed ID: 15840678
    [No Abstract]   [Full Text] [Related]  

  • 16. Using the Delphi technique in economic evaluation: time to revisit the oracle?
    Simoens S
    J Clin Pharm Ther; 2006 Dec; 31(6):519-22. PubMed ID: 17176357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluations and diabetes.
    Pathak DS; Burke TA
    Pharm Pract Manag Q; 1998 Jan; 17(4):17-24. PubMed ID: 10174745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard development. Europe.
    Med Care; 1996 Dec; 34(12 Suppl):DS189-90. PubMed ID: 8999205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.